Ryan Specialty Holdings, Inc.
RYANRyan Specialty Holdings, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is topping out (1 weeks in) while the P/BV sits at the 8th percentile of its own 5-year range. Underneath, the last four quarters read improving, with the the net margin at 5.0%. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Ryan Specialty Holdings, Inc. trades at $46.0, losing momentum at the top and 1 weeks into that stage. That is +6.2% against its own 200-day average. It sits at 54% of a 52-week range of $31 to $59. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 6 straight weeks.
Today the stock is losing momentum at the top — week 1 of stage 3. At $46.0 it trades +6.2% versus its 200-day average and sits at 54% of its 52-week range ($31–$59).
Against the market, two honest reads. Cumulative: over the last 5.0 years the stock moved +61% while the S&P 500 moved +68% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 6 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/BV sits at the 8th percentile of its own range.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each $1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
Ryan Specialty Holdings, Inc. trades at 8.8× P/BV, near the bottom of its own range — cheaper only 8% of the time. Its long-run median P/BV is 14.3×, measured across 4.8 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 8.8× is near the bottom of its own range — cheaper only 8% of the time, against a long-run median of 14.3× measured over 4.8 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year book value grew while the price moved −30.6% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 5y, of the +9.3%/yr price move, ~+9.3%/yr came from book-value growth and ~+0.0 pp from the multiple (roughly flat). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the book-value line underneath it, not the multiple.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Ryan Specialty Holdings, Inc. reads as turning around on its fundamental arc. Turning around — profit growth swung from −12.0% at the trough to +31.6%, a 2-quarter improving streak, ROE lifting at 20.5%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +21.0% | +20.8% | — | — |
| Profit | −8.7% | +9.5% | — | — |
| EPS | −33.8% | −3.3% | — | — |
| Stock price | −30.6% | +1.7% | +9.3% | — |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
48.6/100 — rank 6 of 17 in Insurance - Specialty · 67% evidence confidence
Ryan Specialty Holdings, Inc. scores 48.6 out of 100 against the 17 companies it is compared with in Insurance - Specialty, ranking 6. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 25.1 + 11.4 + 3 + 9.1 = 48.6. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fees from its businesses.
Ryan Specialty Holdings, Inc. reported $0.8 B of income in the Mar 26 quarter, +15.9% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 20.8% a year. The last full year, FY25, came in at $3.0 B. The last four reported quarters add to $3.2 B.
Ryan Specialty Holdings, Inc. reported $0.8 B of income in the Mar 26 quarter, +15.9% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 20.8% a year. The last full year, FY25, came in at $3.0 B. The last four reported quarters add to $3.2 B.
FY25 revenue came in at $3.0 B (+21.0% on the year), capping 4 years at 20.8% compound. The latest quarter (Mar 26) printed $0.8 B, +15.9% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +19.4% growth against the decade's 20.8% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +19.2% over the last 4 quarters against +20.7%/yr over the last 8 — stabilising; TTM profit +31.6% vs +11.8%/yr — accelerating.
→ Revenue grew — did the net margin hold as it scaled? Next: 5.0% this quarter (+5.0 pp YoY).
Net margin Net margin — what the bank keeps of every $100 of revenue after every cost, provision and tax. With big fee businesses in the mix, it is the cleanest margin we can read for this bank.
Ryan Specialty Holdings, Inc.'s net margin is 5.0% in the Mar 26 quarter, +5.0 percentage points against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 4.2% to 9.2%. The current quarter sits inside that band.
Ryan Specialty Holdings, Inc.'s net margin is 5.0% in the Mar 26 quarter, +5.0 percentage points against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 4.2% to 9.2%. The current quarter sits inside that band.
The latest quarter's net margin is 5.0%, +5.0 pp against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 4.2%–9.2%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
→ The net margin held — did that reach the bottom line? Next: profit null in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Ryan Specialty Holdings, Inc. earned $0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $0.2 B. The 4-year compound rate is 36.8%. That is 5.0% of the quarter's revenue. The same quarter a year earlier earned $0.0 B.
Ryan Specialty Holdings, Inc. earned $0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $0.2 B. The 4-year compound rate is 36.8%. That is 5.0% of the quarter's revenue. The same quarter a year earlier earned $0.0 B.
Mar 26 profit was $0.0 B, null year on year. On the full year, FY25 printed $0.2 B (−8.7%), and the 4-year compound rate is 36.8%.
Pace comparison, last four quarters: profit +25.0% vs revenue +19.4%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
→ Profit is up — how clean is the loan book behind it? Next: we hold no quarterly loan-book numbers — the section says so plainly.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for Ryan Specialty Holdings, Inc., so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
→ Behind the profits — is the book itself still growing? Next: revenue grew +21.0% in FY25.
The loan book We read the loan book through revenue — when the book and the businesses grow, revenue grows with them. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
Ryan Specialty Holdings, Inc.'s revenue grew +21.0% in FY25 to $3.0 B, so the book is growing. The latest quarter ran +15.9% year on year. The net margin on that income is 5.0%, +5.0 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.
FY25 revenue was $3.0 B, +21.0% on the year, and the latest quarter ran +15.9% year on year. The net margin on that revenue is 5.0% this quarter (+5.0 pp YoY) — growth with a widening margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — with quarterly loan-quality numbers missing here, revenue growth and margin are the two we watch.
→ Does all of this actually earn its keep on equity? Next: ROE is 23%.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
Ryan Specialty Holdings, Inc. earns a return on equity of 17% in FY25. Its trough over the ladder below was 10% in FY21. On the asset side every $100 of the balance sheet earned about $3.62, which is the return before leverage is applied.
FY25 ROE came in at 17%, recovered from a FY21 trough of 10%. On assets, the latest reading is about 3.62% — every $100 the bank deploys earns roughly $3.62 a year. That clears the bar a bank must beat for its book value to compound.
Why ROE moved: profit compounded 36.8% a year over 4 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.
→ Who owns this bank, and are they adding or leaving? Next: short interest is 14.7% of the float.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
Ryan Specialty Holdings, Inc. paid $0.49 per share over the last four reported quarters, up 8.3% on a year ago. The most recent declaration was $0.13 for Mar 26. Against the current price of $46.0 that is a trailing yield of 1.06%, measured on dividends already paid rather than on a forecast.
Ryan Specialty Holdings, Inc. paid $0.49 per share over the last four reported quarters, up 8.3% on a year ago. The most recent declaration was $0.13 for Mar 26. Against the current price of $46.0 that is a trailing yield of 1.06%, measured on dividends already paid rather than on a forecast.
Ryan Specialty Holdings, Inc. paid $0.49 per share across the last four reported quarters, most recently $0.13 for Mar 26. That is up 8.3% against the same quarter a year earlier. Against the current price of $46.0 the trailing twelve months work out to 1.06% — trailing dividends measured against today's price, not a forward estimate.
→ A payout is cash leaving the business. Next: what the balance sheet looks like behind it.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
→ Who owns this, and are they adding or leaving? Next: short interest is 14.7% of the float.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
14.7% of Ryan Specialty Holdings, Inc.'s tradable float is currently sold short — a large bloc is positioned against it. At typical trading volumes those positions would take about 7.0 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 14.7% of the float is sold short, and at typical trading volumes it would take about 7.0 days to buy those positions back. A large bloc is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Ryan Specialty Holdings, Inc.: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
| Company | P/BV | Mkt cap | Revenue | EPS | ROE | Stage |
|---|---|---|---|---|---|---|
| Ryan Specialty Holdings, Inc. this page | 8.8× | $12B | Turning around | |||
| Fidelity National Financial, Inc. | 2.0× | $15B | Deteriorating | |||
| AXIS Capital Holdings Limited | 1.5× | $9B | Consistent | |||
| First American Financial Corporation | 1.4× | $8B | Mixed | |||
| Enact Holdings, Inc. | 1.3× | $7B | Mixed | |||
| MGIC Investment Corporation | 1.3× | $6B | Deteriorating | |||
| Essent Group Ltd. | 1.1× | $6B | Mixed | |||
| Radian Group Inc. | 1.1× | $5B | Improving | |||
| Assured Guaranty Ltd. | 0.7× | $4B | Improving | |||
| NMI Holdings, Inc. | 1.3× | $3B | Consistent | |||
| Employers Holdings, Inc. | 1.1× | $1B | Deteriorating | |||
| Tiptree Inc. | 1.3× | $1B | Deteriorating | |||
| AMERISAFE, Inc. | 2.3× | $1B | Turning around | |||
| Investors Title Company | 2.0× | $1B | Mixed | |||
| MBIA Inc. | — | $0B | No read | |||
| Octave Specialty Group, Inc. | 0.4× | $0B | Turning around | |||
| James River Group Holdings, Inc. | 0.4× | $0B | Deteriorating |
Frequently asked questions
What is Ryan Specialty Holdings, Inc.'s stock price today?
Ryan Specialty Holdings, Inc. trades at $46.0, −30.6% over the past year. The company is valued at $12.0 B. The stock sits at 54% of its 52-week range of $31–$59, +6.2% versus its 200-day average. On the tape, the price is topping out, 1 weeks in. — as of 29 July 2026.
What were Ryan Specialty Holdings, Inc.'s latest quarterly results?
Ryan Specialty Holdings, Inc. reported total income of $0.8 B and net profit of $0.0 B for the Mar 26 quarter. Earnings per share were $0.13. The net margin was 5.0%, 5.0 pp higher than a year earlier. — as of 29 July 2026.
What is Ryan Specialty Holdings, Inc.'s revenue?
Ryan Specialty Holdings, Inc. reported revenue of $0.8 B in the Mar 26 quarter, +15.9% year on year. For the full FY25 fiscal year, revenue was $3.0 B (+21.0%). Over the last 4 years revenue compounded at 20.8% a year. — as of 29 July 2026.
What is Ryan Specialty Holdings, Inc.'s profit?
Ryan Specialty Holdings, Inc. earned $0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $0.2 B. The net margin ran 5.0% in the latest quarter. — as of 29 July 2026.
What is Ryan Specialty Holdings, Inc.'s market cap?
Ryan Specialty Holdings, Inc.'s market capitalisation is $12.0 B at a stock price of $46.0. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 29 July 2026.
What is Ryan Specialty Holdings, Inc.'s P/BV ratio?
Ryan Specialty Holdings, Inc. trades at a P/BV of 8.8×, at the 8th percentile of its own 5-year range, against a long-run median of 14.3×. This is a comparison with the stock's own history, not a value call — as of 29 July 2026.
Does Ryan Specialty Holdings, Inc. pay a dividend?
Yes — Ryan Specialty Holdings, Inc. declared $0.13 per share for Mar 26, and $0.49 per share across the last four reported quarters. The latest quarter is up 8.3% on the same quarter a year earlier. — as of 29 July 2026.
What is Ryan Specialty Holdings, Inc.'s dividend per share?
Ryan Specialty Holdings, Inc.'s most recently declared dividend is $0.13 per share for Mar 26, giving $0.49 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 29 July 2026.
What is Ryan Specialty Holdings, Inc.'s dividend yield?
Ryan Specialty Holdings, Inc.'s trailing dividend yield is 1.06%: $0.49 declared per share across the last four reported quarters, against a share price of $46.0. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 29 July 2026.
Is Ryan Specialty Holdings, Inc. overvalued?
On its own history, Ryan Specialty Holdings, Inc. looks cheap against its own history: its P/BV of 8.8× has been cheaper only 8% of the time in 5 years (long-run median 14.3×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 29 July 2026.
How is Ryan Specialty Holdings, Inc. performing?
Ryan Specialty Holdings, Inc. is topping out, 1 weeks in. Against the S&P 500 it has been ahead on a trailing-13-week view for 6 weeks. This describes what the data did, not a rating. — as of 29 July 2026.
What stage is Ryan Specialty Holdings, Inc. in?
Turning around — profit growth swung from −12.0% at the trough to +31.6%, a 2-quarter improving streak, ROE lifting at 20.5%. The read comes from the last 12 quarters of growth (revenue growth +19.2% latest, profit growth +31.6% latest, eps growth +126.5% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 29 July 2026.
Is Ryan Specialty Holdings, Inc. in an uptrend?
It is stalling — the price is topping out (week 1 of stage 3), trading +6.2% versus its 200-day average and at 54% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 29 July 2026.
Is Ryan Specialty Holdings, Inc. beating the market?
On recent form, yes — Ryan Specialty Holdings, Inc. has been ahead of the S&P 500 on a trailing-13-week view for 6 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 5.0 years the stock moved +61% against the S&P 500's +68% — behind the index over the full window. — as of 29 July 2026.
Will Ryan Specialty Holdings, Inc.'s stock price go up?
This page publishes no price forecast for Ryan Specialty Holdings, Inc. What it measures instead: the stock price is $46.0, the price is topping out 1 weeks in. Its P/BV of 8.8× sits at the 8th percentile of its own 5-year range. — as of 29 July 2026.
Is the market betting against Ryan Specialty Holdings, Inc.?
Yes — short interest is 14.7% of Ryan Specialty Holdings, Inc.'s tradable float, about 7.0 days to cover at typical volumes. A crowded short: a large bloc is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 29 July 2026.
Is Ryan Specialty Holdings, Inc.'s loan book healthy?
We do not hold quarterly loan-book quality numbers for Ryan Specialty Holdings, Inc., so this page says that plainly. The cleanest available reads are revenue growth (+21.0% in FY25) and the net margin on it (5.0%) — as of 29 July 2026.
Where is Ryan Specialty Holdings, Inc. in its business cycle?
Ryan Specialty Holdings, Inc.'s FY25 net margin was 6.9%, against a 5-year band of 4.2%–9.2%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 5.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 29 July 2026.
What could break the Ryan Specialty Holdings, Inc. story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 29 July 2026.
Is Ryan Specialty Holdings, Inc. a stock worth studying right now?
This is not investment advice. The machine read: Ryan Specialty Holdings, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 29 July 2026.